Clinical Pharmacogenetics Implementation Consortium on:
[Wikipedia]
[Google]
[Amazon]
The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international consortium including members of
The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international consortium including members of NIH
The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research. It was founded in 1887 and is part of the United States Department of Health and Human Service ...
Pharmacogenomics Research Network (PGRN), PharmGKB staff, and experts in PGx and medicine, who are committed to facilitating the use of pharmacogenetic tests to improve patient care.
See also
*pharmacogenetics
Pharmacogenomics, often abbreviated "PGx," is the study of the role of the genome in drug response. Its name ('' pharmaco-'' + ''genomics'') reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup o ...
*pharmacogenomics
Pharmacogenomics, often abbreviated "PGx," is the study of the role of the genome in drug response. Its name ('' pharmaco-'' + ''genomics'') reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup o ...
*pharmacokinetics
Pharmacokinetics (from Ancient Greek ''pharmakon'' "drug" and ''kinetikos'' "moving, putting in motion"; see chemical kinetics), sometimes abbreviated as PK, is a branch of pharmacology dedicated to describing how the body affects a specific su ...
*pharmacodynamics
Pharmacodynamics (PD) is the study of the biochemistry, biochemical and physiology, physiologic effects of drugs (especially pharmaceutical drugs). The effects can include those manifested within animals (including humans), microorganisms, or comb ...
* PharmGKB
* Pharmacogene Variation Consortium
References
National Institutes of Health {{med-org-stub